Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV001027604 | SCV001190175 | pathogenic | Inherited Immunodeficiency Diseases | 2019-01-01 | criteria provided, single submitter | research | |
NIHR Bioresource Rare Diseases, |
RCV001027598 | SCV001190176 | likely pathogenic | Common variable immunodeficiency | 2019-01-01 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV001262753 | SCV001440735 | pathogenic | Immunodeficiency, common variable, 12 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002552007 | SCV003459865 | pathogenic | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg284*) in the NFKB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NFKB1 are known to be pathogenic (PMID: 26279205, 29477724). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal dominant NKFB1 deficiency (PMID: 29477724, 32499645, 32581362, 32918165). ClinVar contains an entry for this variant (Variation ID: 827726). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV001262753 | SCV001571630 | pathogenic | Immunodeficiency, common variable, 12 | 2021-04-20 | no assertion criteria provided | literature only |